194 related articles for article (PubMed ID: 10753056)
1. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
[TBL] [Abstract][Full Text] [Related]
2. Influence of human anti-lipopolysaccharide immunoglobulins on tissue distribution and clearance of lipopolysaccharide in rats.
Nys M; Damas J; Damas P; Laub R; Lamy M
Med Microbiol Immunol; 1999 Nov; 188(2):65-71. PubMed ID: 10753057
[TBL] [Abstract][Full Text] [Related]
3. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
Fomsgaard A; Holder IA
APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
5. Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharides.
Fomsgaard A; Galanos C
APMIS; 1989 Dec; 97(12):1114-20. PubMed ID: 2611025
[TBL] [Abstract][Full Text] [Related]
6. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
7. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.
McCabe WR; DeMaria A; Berberich H; Johns MA
J Infect Dis; 1988 Aug; 158(2):291-300. PubMed ID: 3042871
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model.
Lachmann RA; van Kaam AH; Haitsma JJ; Verbrugge SJ; Delreu F; Lachmann B
Exp Lung Res; 2004 Jun; 30(4):251-60. PubMed ID: 15204832
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia.
Hoffman JN; Fertmann JM; Vollmar B; Laschke MW; Jauch KW; Menger MD
Shock; 2008 Jan; 29(1):133-9. PubMed ID: 18246604
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
12. Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product.
Trautmann M; Held TK; Susa M; Karajan MA; Wulf A; Cross AS; Marre R
Clin Exp Immunol; 1998 Jan; 111(1):81-90. PubMed ID: 9472665
[TBL] [Abstract][Full Text] [Related]
13. An anti-idiotype antibody which mimics the inner-core region of lipopolysaccharide protects mice against a lethal challenge with endotoxin.
Field SK; Morrison DC
Infect Immun; 1994 Sep; 62(9):3994-9. PubMed ID: 8063418
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.
Gallay P; Heumann D; Le Roy D; Barras C; Glauser MP
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7922-6. PubMed ID: 7520172
[TBL] [Abstract][Full Text] [Related]
15. Protective capacity of a IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia.
Oesser S; Schulze C; Seifert J
Res Exp Med (Berl); 1999 Apr; 198(6):325-39. PubMed ID: 10369088
[TBL] [Abstract][Full Text] [Related]
16. Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors.
Fomsgaard A; Baek L; Fomsgaard JS; Engquist A
Scand J Infect Dis; 1989; 21(6):697-708. PubMed ID: 2617211
[TBL] [Abstract][Full Text] [Related]
17. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
[TBL] [Abstract][Full Text] [Related]
18. Administration in vivo of recombinant interleukin 2 protects mice against septic death.
Weyand C; Goronzy J; Fathman CG; O'Hanley P
J Clin Invest; 1987 Jun; 79(6):1756-63. PubMed ID: 3294901
[TBL] [Abstract][Full Text] [Related]
19. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
Dunn DL
Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
[TBL] [Abstract][Full Text] [Related]
20. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis.
Mäki-Ikola O; Lehtinen K; Nissilä M; Granfors K
Br J Rheumatol; 1994 Nov; 33(11):1025-9. PubMed ID: 7981989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
